Tinlarebant. Retinol-binding protein 4 (RBP4) inhibitor, Treatment of Stargardt disease, Treatment of dry age-related macular degeneration

S. Vaccaro, L. Ferro Desideri, P. Bianchi, A. Vagge, R. Manocchio, V. Scorcia, C. Traverso, F. Calabria, G. Giannaccare

2023Drugs of the Future

DOI: 10.1358/dof.2023.48.3.3474539

Abstract

Abstract is not available.

Citation format

VACCARO, S., et al. Tinlarebant. retinol-binding protein 4 (RBP4) inhibitor, treatment of stargardt disease, treatment of dry age-related macular degeneration. Drugs of the Future, 2023.